3.10. Carcinogenicity

Cronin M.T. , Jaworska J.S. , Walker J.D. , Comber M.H. , Watts C.D. , & Worth A.P. (2003). Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. Environmental Health Perspectives 111, 1391–401.

Aaronson S.A. , & Todaro G.J. (1968). Development of 3T3-like line from BALB/c mouse embryo culture: transformation susceptibility to SV40. Journal of Cell Physiology 72, 141–148.

Berwald Y. , & Sachs L. (1963). In vitro transformation of normal cells to tumour cells by carcinogenic hydrocarbons. Journal of National Cancer Institute 35, 641–661.

LeBoeuf R.A. , & Kerchaert G.A. (1987). Enhanced morphological transformation of early passage Syrian hamster embryo cells cultured in medium with a reduced bicarbonate concentration and pH. Carcinogenesis 8, 689–697.

Mondal S. , & Heidelberger C. (1970). In vitro malignant transformation by methylcholanthrene of the progeny of single cells derived from C3H mouse prostate. Proceedings of the National Academy of Sciences of the USA 65, 219–225.

DiPaolo J.A. , Donovan P. , & Nelson R. (1969). Quantitative studies of in vitro transformation by chemical carcinogens. Journal of National Cancer Institute 42, 867–874.

Isfort R.J. , Kerckaert G.A. , & LeBoeuf R.A. (1996). Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals. Mutation Research 356, 11–63.

Matthews E.J. , Spalding J.W. , & Tennant R.W. (1993). Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays. Environmental Health Perspectives 101 Suppl. 2, 347–482.

Rivedal E. , & Sanner T. (1982). Promotional effect of different phorbol esters on morphological transformation of hamster embryo cells. Cancer Letters 17, 1–8.

Yotti L.P. , Chang C.C. , & Trosko J.E. (1979). Elimination of metabolic cooperation in Chinese hamster cells by a tumour promoter. Science, New York 206, 1089–1091.

Murray A.W. , & Fitzgerald D.J. (1979). Tumour promoters inhibit metabolic cooperation in cocultures of epidermal and 3T3 cells. Biochemical and Biophysical Research Communications 91, 395–401.

Blaha L. , Kapplova P. , Vondracek J. , Upham B. , & Machala M. (2002). Inhibition of gap-junctional intercellular communication by environmentally occurring polycyclic aromatic hydrocarbons. Toxicological Sciences 65, 43–51.

Rivedal E. , Mikalsen S.O. , & Sanner T. (2000). Morphological transformation and effect on gap junction intercellular communication in Syrian hamster embryo cells as screening tests for carcinogens devoid of mutagenic activity. Toxicology in Vitro 14, 185–192.

Rosenkranz H.S. , Pollack N. , & Cunningham A.R. (2000). Exploring the relationship between the inhibition of gap junctional intercellular communication and other biological phenomena. Carcinogenesis 21, 1007–1011.

Yamasaki H. , Ashby J. , Bignami M. , Jongen W. , Linnainmaa K. , Newbold R.F. , Nguyen-Ba G. , Parodi S. , Rivedal E. , Schiffmann D. , Simons J.W. , & Vasseur P. (1996). Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project. Mutation Research 353, 47–63.

Tennant R.W. , Stasiewicz S. , Mennear J. , French J.E. , & Spalding J.W. (1999). Genetically altered mouse model for identifying carcinogens. In The use of short and medium-term tests for carcinogens and data on genetic effects in carcinogenic hazard evaluation. ( McGregor D.B. , Rice J.M. , & Venitt S. ed.), IARC Scientific Publication 146 pp. 123–148. Lyon, France: International Agency for research on Cancer.

Dean S.W. , Brooks T.M. , Burlinson B. , Mirsalis J. , Myhr B. , Recio L. , & Thybaud V. (1999). Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens. Mutagenesis 14, 141–51.

MacDonald J. , French J.E. , Gerson R.J. , Goodman J. , Inoue T. , Jacobs A. , Kasper P. , Keller D. , Lavin A. , Long G. , McCullough B. , Sistare F.D. , Storer R. , & van der Laan J.W. (2004). The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI. Toxicological Science 77, 188–94.

Leder A. , Kuo A. , Cardiff R.D. , Sinn E. , & Leder P. (1990). v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proceedings of the National Academy of Sciences of the USA 87, 9178–82.

Harvey M. , McArthur M.J. , Montgomery C.A. Jr. , Butel J.S. , Bradley A. , & Donehower L.A. (1993). Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genetics 5, 225–229.

Yamamoto S. , Hayashi Y. , Mitsumori K. , & Nomura T. (1997). Rapid carcinogenicity testing system with transgenic mice harbouring human prototype c-HRAS gene. Laboratory Animal Science 47, 121–6.

Botwell R.K. (1964). Some biological aspects of skin carcinogenesis. Progress in Experimental Tumor Research 4, 207–250.